PL3463281T3 - Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania - Google Patents

Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania

Info

Publication number
PL3463281T3
PL3463281T3 PL17733738.3T PL17733738T PL3463281T3 PL 3463281 T3 PL3463281 T3 PL 3463281T3 PL 17733738 T PL17733738 T PL 17733738T PL 3463281 T3 PL3463281 T3 PL 3463281T3
Authority
PL
Poland
Prior art keywords
beta
dosage forms
inhibitory activity
aerosol dosage
elastase inhibitory
Prior art date
Application number
PL17733738.3T
Other languages
English (en)
Inventor
Piet BRUIJNZEEL
Johann Zimmermann
Philip BARTH
Eric Chevalier
Christian Ludin
Manfred Keller
Original Assignee
Spexis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spexis Ag filed Critical Spexis Ag
Publication of PL3463281T3 publication Critical patent/PL3463281T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
PL17733738.3T 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania PL3463281T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16020210 2016-05-31
PCT/EP2017/025157 WO2017207118A1 (en) 2016-05-31 2017-05-31 Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

Publications (1)

Publication Number Publication Date
PL3463281T3 true PL3463281T3 (pl) 2022-11-07

Family

ID=56108445

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17733738.3T PL3463281T3 (pl) 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania
PL17733737.5T PL3463280T3 (pl) 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17733737.5T PL3463280T3 (pl) 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania

Country Status (27)

Country Link
US (3) US11235023B2 (pl)
EP (2) EP3463281B1 (pl)
JP (4) JP7286319B6 (pl)
KR (2) KR102480800B1 (pl)
CN (3) CN109195580A (pl)
AU (2) AU2017273508B2 (pl)
BR (2) BR112018074532B1 (pl)
CA (2) CA3024522C (pl)
CL (2) CL2018003391A1 (pl)
DK (2) DK3463280T3 (pl)
EA (2) EA039603B1 (pl)
ES (2) ES2927948T3 (pl)
HR (2) HRP20221185T1 (pl)
HU (2) HUE060119T2 (pl)
IL (2) IL263112B2 (pl)
LT (2) LT3463281T (pl)
MA (2) MA45168A (pl)
MX (2) MX393629B (pl)
PH (2) PH12018502522A1 (pl)
PL (2) PL3463281T3 (pl)
PT (2) PT3463281T (pl)
RS (2) RS63622B1 (pl)
SG (3) SG11201810137UA (pl)
SM (2) SMT202200405T1 (pl)
UA (2) UA125899C2 (pl)
WO (2) WO2017207117A1 (pl)
ZA (2) ZA201807772B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX393629B (es) * 2016-05-31 2025-03-24 Polyphor Ag Beta-horquilla peptidomimetica con actividad inhibidora de elastasa y formas de dosificacion en aerosol de la misma.
JP2022544834A (ja) * 2019-08-23 2022-10-21 ピーエイチ・ファーマ・カンパニー・リミテッド 肺疾患における好中球エラスターゼ阻害剤の使用
BR112022014861A2 (pt) * 2020-01-30 2022-09-20 Vertex Pharma Métodos de tratamento para deficiência de alfa-1 antittripsina
WO2021203014A1 (en) 2020-04-03 2021-10-07 Vertex Pharmaceuticals Incorporated Pyrano[4,3-b]l ndole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)
EP4126863A1 (en) 2020-04-03 2023-02-08 Vertex Pharmaceuticals Incorporated 1 h-pyrazolo[4,3-g]isoquinoline and 1 h-pyrazolo[4,3-g]quinoline derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)
JP2023549971A (ja) * 2020-11-23 2023-11-29 スペクシス アーゲー ベータヘアピン型ペプチド模倣物の組成物及びそのエアロゾル投与形態
CN116421704A (zh) * 2023-02-20 2023-07-14 成都佩德生物医药有限公司 多肽pd-dp-005在制备治疗肺部疾病药物中的应用及其药物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998019694A1 (en) 1996-11-01 1998-05-14 Xoma Corporation Therapeutic uses of bpi protein products in cystic fibrosis patients
US20060188555A1 (en) * 2005-01-21 2006-08-24 Micheal Cormier Therapeutic peptide formulations with improved stability
CA2598360C (en) * 2005-02-17 2016-12-20 Universitat Zurich Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
PT1981572E (pt) * 2006-02-09 2013-02-26 Pari Pharma Gmbh Distribuição pulmonar de inibidor de alfa-i proteinase
JP2009526003A (ja) * 2006-02-10 2009-07-16 パーリ・ファルマ・ゲーエムベーハー 吸入療法用噴霧状抗生物質
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
EP1927373B1 (en) * 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
PL2567691T3 (pl) * 2011-09-12 2015-05-29 Meiji Seika Pharma Co Ltd Kompozycje wodne obejmujące arbekacynę
WO2015096672A1 (zh) 2013-12-23 2015-07-02 石家庄铁道大学 测试装置
JP6431486B2 (ja) 2013-12-26 2018-11-28 株式会社カネカ 太陽電池のｉ‐ｖ測定方法、太陽電池のｉ‐ｖ測定装置、太陽電池の製造方法、太陽電池モジュールの製造方法、および太陽電池モジュール
NZ722025A (en) * 2013-12-27 2019-06-28 Polyphor Ag Beta-hairpin peptidomimetics as selective elastase inhibitors
EA034910B1 (ru) * 2013-12-27 2020-04-06 Полифор Аг Бета-шпилечные пептидомиметики в качестве селективных ингибиторов эластазы
MX393629B (es) * 2016-05-31 2025-03-24 Polyphor Ag Beta-horquilla peptidomimetica con actividad inhibidora de elastasa y formas de dosificacion en aerosol de la misma.

Also Published As

Publication number Publication date
US20200230202A1 (en) 2020-07-23
WO2017207117A1 (en) 2017-12-07
HUE060393T2 (hu) 2023-02-28
KR102480800B1 (ko) 2022-12-22
UA125899C2 (uk) 2022-07-06
JP7544466B2 (ja) 2024-09-03
DK3463281T3 (da) 2022-09-26
JP2023017793A (ja) 2023-02-07
LT3463281T (lt) 2022-09-26
MX393629B (es) 2025-03-24
IL263114B2 (en) 2023-12-01
JP2022078013A (ja) 2022-05-24
EP3463280B1 (en) 2022-07-06
DK3463280T3 (da) 2022-09-26
PH12018502522A1 (en) 2019-10-21
US20220023379A1 (en) 2022-01-27
AU2017273507B2 (en) 2022-03-17
EA201892819A1 (ru) 2019-05-31
MX2018014425A (es) 2019-03-28
BR112018074551B1 (pt) 2022-02-08
EA201892818A1 (ru) 2019-05-31
EP3463281B1 (en) 2022-07-06
SMT202200405T1 (it) 2022-11-18
LT3463280T (lt) 2022-09-26
PL3463280T3 (pl) 2022-11-07
PH12018502521A1 (en) 2019-10-21
UA125900C2 (uk) 2022-07-06
CL2018003390A1 (es) 2019-05-03
BR112018074532A2 (pt) 2019-03-19
EP3463280A1 (en) 2019-04-10
IL263114B1 (en) 2023-08-01
SG11201810138XA (en) 2018-12-28
AU2017273508B2 (en) 2022-07-28
JP7286319B6 (ja) 2023-06-16
IL263112B1 (en) 2023-06-01
PT3463281T (pt) 2022-10-07
US11235024B2 (en) 2022-02-01
CA3024521C (en) 2023-06-20
CN116159024A (zh) 2023-05-26
HRP20221185T1 (hr) 2022-12-09
KR102511284B1 (ko) 2023-03-16
US11235023B2 (en) 2022-02-01
SG10202113280XA (en) 2021-12-30
IL263112B2 (en) 2023-10-01
BR112018074532B1 (pt) 2022-02-08
AU2017273507A1 (en) 2018-12-13
IL263114A (en) 2018-12-31
AU2017273508A1 (en) 2018-12-13
EA039603B1 (ru) 2022-02-16
ZA201807772B (en) 2022-10-26
US20200230203A1 (en) 2020-07-23
MA45167A (fr) 2019-04-10
SG11201810137UA (en) 2018-12-28
CA3024522A1 (en) 2017-12-07
HUE060119T2 (hu) 2023-02-28
JP2019523222A (ja) 2019-08-22
HRP20221194T1 (hr) 2022-12-09
JP7286319B2 (ja) 2023-06-05
BR112018074551A2 (pt) 2019-03-06
EP3463281A1 (en) 2019-04-10
PT3463280T (pt) 2022-10-07
CN109310613A (zh) 2019-02-05
JP2019523763A (ja) 2019-08-29
CL2018003391A1 (es) 2019-05-03
RS63639B1 (sr) 2022-10-31
ES2928050T3 (es) 2022-11-15
RS63622B1 (sr) 2022-10-31
CA3024522C (en) 2024-06-25
CN109195580A (zh) 2019-01-11
ZA201807773B (en) 2022-07-27
KR20190015309A (ko) 2019-02-13
US11844823B2 (en) 2023-12-19
MX2018014752A (es) 2019-04-25
KR20190011750A (ko) 2019-02-07
WO2017207118A1 (en) 2017-12-07
IL263112A (en) 2018-12-31
CA3024521A1 (en) 2017-12-07
ES2927948T3 (es) 2022-11-14
SMT202200404T1 (it) 2022-11-18
MA45168A (fr) 2019-04-10

Similar Documents

Publication Publication Date Title
ZA201807772B (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
IL257706A (en) Peptidomimetic macrocycles and their uses
ZA201702162B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
IL254444A0 (en) Peptidomimetic macrocycles and their uses
EP3114217A4 (en) Caspase polypeptides having modified activity and uses thereof
GB201516555D0 (en) Event detection and summarisation
ZA201702168B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
ZA201509326B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
EP3255059A4 (en) Antimicrobial peptide wy-21 and use thereof
EP3072519A4 (en) Peptide having angiogenesis inhibitory activity and composition containing same
ZA201804864B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
EP3263584A4 (en) Peptide for targeting autophagic cells and use thereof
IL274353A (en) Heterocyclic inhibitors of mitochondrial activity and their uses
EP3305895A4 (en) Beta-galactosidase variant having high transglycosylation activity, and use thereof
IL283619A (en) Compounds with pde9a prophylactic activity, and their medicinal use
ZA201907737B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
PL3438118T3 (pl) Pochodna peptydu i jej zastosowanie
IL273655B1 (en) A compound with erk kinase inhibitory activity and its use
EP3325499A4 (en) Novel peptide and use thereof
GB2568553B (en) Activity detection
IL283620A (en) Compounds with pde9a prophylactic activity, and their medicinal uses
GB201617761D0 (en) Medicament and assay
AU2015902816A0 (en) Spray device and dosage cartridge
GB201514855D0 (en) Valve and button system
FR3041047B1 (fr) Couvercle avec doigt d'arret d'ecrou